article thumbnail

ChatGPT can (almost) pass the US Medical Licensing Exam

Medical Xpress

ChatGPT can score at or around the approximately 60% passing threshold for the United States Medical Licensing Exam (USMLE), with responses that make coherent, internal sense and contain frequent insights, according to a study published February 9, 2023, in the open-access journal PLOS Digital Health by Tiffany Kung, Victor Tseng, and colleagues at (..)

article thumbnail

Gilead wins patent battle with US government over HIV PrEP drugs

Pharmaceutical Technology

According to the US government, Gilead had repeatedly refused to license patents related to PrEP research undertaken by the Department of Health and Human Services’ (HHS) Centers for Disease Control and Prevention (CDC). While both Descovy and Truvada contain emtricitabine, they feature different forms of the antiviral tenofovir.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

India’s Hetero receives WHO approval for Nirmacom to treat Covid-19

Pharmaceutical Technology

Hetero’s Nirmacom combi-pack will contain nirmatrelvir 150 mg (two tablets) and ritonavir 100mg (one tablet). The company has signed a non-exclusive voluntary licensing agreement with Medicines Patent Pool (MPP) to produce and sell nirmatrelvir in LMICs.

Licensing 195
article thumbnail

Cantex secures license to develop small molecule-drug for inflammatory lung diseases

pharmaphorum

The post Cantex secures license to develop small molecule-drug for inflammatory lung diseases appeared first on. It is currently the only oral small molecule RAGE inhibitor in human clinical trials.

article thumbnail

Syncromune and Eucure enter antibody licence deal

Pharmaceutical Technology

According to the deal, the worldwide rights for developing and marketing intratumoral combination treatment containing Eucure’s YH002 and two additional active ingredients of the Syncrovax therapy will be acquired by Syncromune.

Antibody 130
article thumbnail

Birth control study suggests estrogen dosage could be drastically cut: Here's what you should know

Medical Xpress

The amount of estrogen the birth control pill currently contains is already substantially lower than it was when the pill was first licensed more than 60 years ago. But a new paper has suggested that the doses of both estrogen and progestogen in the pill could be significantly reduced and still work to prevent pregnancy.

article thumbnail

AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development

The Pharma Data

a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation, today announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences for COVID-19 therapy development. View source version on businesswire.com: [link].